Your browser doesn't support javascript.
loading
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.
Fontana, Elisa; Meyers, Jeff; Sobrero, Alberto; Iveson, Timothy; Shields, Anthony F; Taieb, Julien; Yoshino, Takayuki; Souglakos, Ioannis; Smyth, Elizabeth C; Lordick, Florian; Moehler, Markus; Giraut, Anne; Harkin, Andrea; Labianca, Roberto; Meyerhardt, Jeffrey; André, Thierry; Boukovinas, Ioannis; Lonardi, Sara; Saunders, Mark; Vernerey, Dewi; Oki, Eiji; Georgoulias, Vassilis; Ben-Aharon, Irit; Shi, Qian.
Afiliação
  • Fontana E; Sarah Cannon Research Institute UK, London, United Kingdom.
  • Meyers J; Gastrointestinal Tract Cancer Group, EORTC, Brussels, Belgium.
  • Sobrero A; Department of Quantitative Health Science, Mayo Clinic, Rochester, MN.
  • Iveson T; Medical Oncology, Policlinico San Martino, Genova, Italy.
  • Shields AF; University of Southampton, Southampton, United Kingdom.
  • Taieb J; Karmanos Cancer Institute, Detroit, MI.
  • Yoshino T; Université de Paris and Georges-Pompidou European Hospital, Paris, France.
  • Souglakos I; National Cancer Center Hospital East, Chiba, Japan.
  • Smyth EC; Laboratory of Translational Oncology, Faculty of Medicine, University of Crete, Crete, Greece.
  • Lordick F; Department of Medical Oncology, University Hospital of Heraklion, Iraklio, Greece.
  • Moehler M; Gastrointestinal Tract Cancer Group, EORTC, Brussels, Belgium.
  • Giraut A; Addenbrookes Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Harkin A; Gastrointestinal Tract Cancer Group, EORTC, Brussels, Belgium.
  • Labianca R; Department of Medicine II, University Cancer Center Leipzig, Leipzig University Medical Center, Leipzig, Germany.
  • Meyerhardt J; Gastrointestinal Tract Cancer Group, EORTC, Brussels, Belgium.
  • André T; I. Department of Internal Medicine, University Medical Center Mainz, Mainz, Germany.
  • Boukovinas I; EORTC Headquarters, Brussels, Belgium.
  • Lonardi S; CRUK Glasgow CTU, Institute of Cancer Sciences, University of Glasgow, United Kingdom.
  • Saunders M; Ospedale Papa Giovanni XXIII, Bergamo, Italy.
  • Vernerey D; Dana-Farber Cancer Institute, Boston, MA.
  • Oki E; Sorbonne Université and Hôpital Saint Antoine, Paris, France.
  • Georgoulias V; Bioclinic Thessaloniki, Thessaloniki, Greece.
  • Ben-Aharon I; Medical Oncology 3, Veneto Institute of Oncology IRCCS, Padua, Italy.
  • Shi Q; The Christie NHS Foundation Trust, Manchester, United Kingdom.
J Clin Oncol ; 39(36): 4009-4019, 2021 12 20.
Article em En | MEDLINE | ID: mdl-34752136
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Fluoruracila / Oxaliplatina Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Fluoruracila / Oxaliplatina Idioma: En Ano de publicação: 2021 Tipo de documento: Article